ArticleCurrent cancer drug targets2025

Antibody-Drug Conjugates (ADCs): A Novel Therapy for Triple-Negative Breast Cancer (TNBC).

Gaurav Gupta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.